Franklin Templeton Australia has launched the Franklin Australian Absolute Return Bond Fund – Class A, an actively managed fixed income fund now available on the ASX. The fund aims to deliver returns exceeding the Bloomberg AusBond Bank Bill Index with a medium risk profile and transparent fee structure.
Franklin Templeton Australia has launched the Franklin Global Growth Fund – Class A, an actively managed ETF listed on the ASX aiming to outperform the MSCI World ex Australia Index with a strong ESG commitment and a 0.90% management fee.
OncoSil Medical has affirmed the materiality of the PANCOSIL Phase 1-2 trial results and detailed its compliance with ASX disclosure rules following the data presentation at CIRSE 2025.
Andromeda Metals has responded to ASX queries regarding its commissioned East Coast Research report, clarifying compliance with disclosure rules and differences in project assumptions.
Pengana International Equities has acknowledged breaching ASX disclosure rules by sharing details of a new private credit strategy with media before official announcement, prompting a policy overhaul.